PARP inhibitors

Nov 04, 2024

CDK7 Inhibitors: A Promising Class in Cancer Therapeutics

Feb 24, 2023

A Quick Recap from ASCO GU 2023: Prostate and Urothelial Cancer Highlights

Mar 02, 2022

PARP inhibitors in Urothelial carcinoma (UC): Hit or miss?

Jan 10, 2022

Novel and Emerging Metastatic Colorectal Cancer Treatment Drugs Anticipated to Change Market Dynamics

Aug 21, 2017

PARP Inhibitors making inroads into Ovarian Cancer

Apr 19, 2017

The Snippet: Targeting metabolism in Renal Cell Carcinoma

Newsletter/Whitepaper